Prostate cancer remains one of the most prevalent malignancies affecting men worldwide and continues to represent a significant clinical challenge due to its heterogeneous biological behavior, delayed diagnosis, and variability in treatment response. Conventional diagnostic approaches primarily rely on prostate-specific antigen (PSA) testing, digital rectal examination, imaging techniques, and histopathological evaluation. Although these methods have substantially improved early detection, they remain constrained by false-positive diagnoses, overdiagnosis of indolent tumors, and limited capability in identifying complex latent relationships embedded within multidimensional clinical datasets. Recent advances in artificial intelligence have demonstrated considerable potential for enhancing clinical decision-making through automated data analysis; however, most existing predictive frameworks depend heavily on supervised learning techniques requiring large quantities of accurately labeled medical data. The availability of such annotated datasets remains a major limitation in real-world healthcare environments.

This research proposes a deep unsupervised artificial intelligence model capable of automatically identifying hidden clinical patterns associated with prostate cancer progression through latent feature discovery and multidimensional clinical data analysis. The proposed conceptual framework integrates clinical variables, demographic characteristics, hormonal indicators, genetic susceptibility, and disease progression markers into a hierarchical representation learning architecture. Unlike traditional prediction models, the framework emphasizes autonomous feature extraction, clustering of patient phenotypes, anomaly detection, and latent representation learning to improve disease prediction without extensive dependence on manual annotations. The study further discusses methodological considerations, analytical findings, clinical implications, and limitations associated with implementing unsupervised AI within precision oncology. The proposed model contributes to future intelligent clinical decision support systems by demonstrating how hidden structures within heterogeneous medical datasets may enhance diagnostic efficiency, patient stratification, and personalized treatment planning while supporting trustworthy human-centered AI deployment in healthcare.